Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial.
Journal: Nature medicine
Published: July 25, 2025
Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults.
Journal: The lancet. HIV
Published: November 15, 2024
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Journal: Science translational medicine
Published: April 19, 2023
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans.
Journal: Science translational medicine
Published: April 19, 2023
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Journal: Lancet (London, England)
Published: September 02, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones.
Journal: Nature communications
Published: July 06, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim Analysis.
Journal: Research square
Published: May 13, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones.
Journal: bioRxiv : the preprint server for biology
Published: April 05, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.
Journal: EClinicalMedicine
Published: March 28, 2022
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
Journal: The New England journal of medicine
Published: January 26, 2022
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization.
Journal: medRxiv : the preprint server for health sciences
Published: December 21, 2021
Last Updated: 09/26/2026